Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge

Vaccine

Volumn 25, Issue 52, 2007, Pages 8702-8706

  Munro, Patrick ^a   Flatau, Gilles ^a   Lemichez, Emmanuel ^a,b  

^a INSERM   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

CNF1; Tetanus toxin; Vaccination

Indexed keywords

CYTOTOXIC NECROTIZING FACTOR 1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; OVALBUMIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TETANUS ANTIBODY; TETANUS TOXIN; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; LD 50; LETHALITY; MOUSE; MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; TETANUS; TETANUS PROPHYLAXIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; NASAL LAVAGE FLUID; SURVIVAL ANALYSIS; TETANUS; TETANUS TOXOID;

EID: 36749003790     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.024     Document Type: Article

References (24)

1. Giudice E.L., and Campbell J.D. Needle-free vaccine delivery. Adv Drug Deliv Rev 58 (2006) 68-89
2. Neutra M.R., and Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6 2 (2006) 148-158
3. Lycke N., Tsuji T., and Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 22 9 (1992) 2277-2281
4. Holmgren J., Lycke N., and Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11 12 (1993) 1179-1184
5. Pizza M., Giuliani M.M., Fontana M.R., Monaci E., Douce G., Dougan G., et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19 17-19 (2001) 2534-2541
6. Munro P., Flatau G., Anjuere F., Hofman V., Czerkinsky C., and Lemichez E. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties. Vaccine 23 20 (2005) 2551-2556
7. Landraud L., Gauthier M., Fosse T., and Boquet P. Frequency of Escherichia coli strains producing the cytotoxic necrotizung factor (CNF1) in nosocomial urinary tract infections. Lett Appl Microbiol 30 3 (2000) 213-216
8. Real J.M., Munro P., Buisson-Touati C., Lemichez E., Boquet P., and Landraud L. Specificity of immunomodulator secretion in urinary samples in response to infection by alpha-hemolysin and CNF1 bearing uropathogenic Escherichia coli. Cytokine 37 1 (2007) 22-25
9. Kim K.J., Chung J.W., and Kim K.S. 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. J Biol Chem 280 2 (2005) 1360-1368
10. Munro P., and Lemichez E. Bacterial toxins activating Rho GTPases. Curr Top Microbiol Immunol 291 (2005) 177-190
11. Flatau G., Lemichez E., Gauthier M., Chardin P., Paris S., Fiorentini C., et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387 6634 (1997) 729-733
12. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., and Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387 6634 (1997) 725-729
13. Doye A., Mettouchi A., Bossis G., Clement R., Buisson-Touati C., Flatau G., et al. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 111 4 (2002) 553-564
14. Lerm M., Pop M., Fritz G., Aktories K., and Schmidt G. Proteasomal degradation of cytotoxic necrotizing factor 1-activated rac. Infect Immun 70 8 (2002) 4053-4058
15. Boyer L., Turchi L., Desnues B., Doye A., Ponzio G., Mege J.L., et al. CNF1-induced ubiquitylation and proteasome destruction of activated RhoA is impaired in Smurf1-/- cells. Mol Biol Cell 17 6 (2006) 2489-2497
16. Doye A., Boyer L., Mettouchi A., and Lemichez E. Ubiquitin-mediated proteasomal degradation of Rho proteins by the CNF1 toxin. Methods Enzymol 406 (2006) 447-456
17. Munro P., Flatau G., Doye A., Boyer L., Oregioni O., Mege J.L., et al. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. J Biol Chem 279 34 (2004) 35849-35857
18. Falzano L., Quaranta M.G., Travaglione S., Filippini P., Fabbri A., Viora M., et al. Cytotoxic necrotizing factor 1 enhances reactive oxygen species-dependent transcription and secretion of proinflammatory cytokines in human uroepithelial cells. Infect Immun 71 7 (2003) 4178-4181
19. Boquet P., Duflot E., and Hauttecoeur B. Low pH induces a hydrophobic domain in the tetanus toxin molecule. Eur J Biochem 144 2 (1984) 339-344
20. Anjuère F., George-Chandy A., Audant F., Rousseau D., Holmgren J., and Czerkinsky C. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses. J Immunol 170 3 (2003) 1586-1592
21. Matoba N., Magerus A., Geyer B.C., Zhang Y., Muralidharan M., Alfsen A., et al. A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc Natl Acad Sci USA 101 37 (2004) 13584-13589
22. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl. 2 (2003) S89-S95
23. Caprioli A., Falbo V., Roda L.G., Ruggeri F.M., and Zona C. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect Immun 39 3 (1983) 1300-1306
24. Diana G., Valentini G., Travaglione S., Falzano L., Pieri M., Zona C., et al. Enhancement of learning and memory after activation of cerebral Rho GTPases. Proc Natl Acad Sci USA 104 2 (2007) 636-641